T1	Procedure 25 39	Histologically
E1	Procedure:T1 Name:T130
T2	Or 40 42	or
E2	Or:T2 Arg:E1 Arg2:E3
T3	Procedure 43 56	cytologically
E3	Procedure:T3 Name:T76
T4	Negation 67 70	non
E4	Negation:T4 Negates:E5
T5	Modifier 71 86	small cell lung
E5	Modifier:T5 Modifies:T77
T6	Condition 87 93	cancer
E6	Condition:T6 Name:T77
T7	Observation 104 108	ECOG
E7	Observation:T7 Name:T78 Eq-Comparison:E8
T8	Eq-Comparison 140 143	0-1
E8	Eq-Comparison:T8 Value:T79 Value2:T131 Operator:T132
T9	Modifier 150 166	Locally advanced
E9	Modifier:T9 Modifies:T80
T10	Or 167 169	or
E10	Or:T10 Arg:E9 Arg2:E11
T11	Modifier 170 190	recurrent metastatic
E11	Modifier:T11 Modifies:T80
T12	Condition 191 196	NSCLC
E12	Condition:T12 Name:T80
T13	Eq-Comparison 212 220	received
E13	Eq-Comparison:T13 Temporal-Period:T81
T14	Procedure 221 239	systemic treatment
E14	Procedure:T14 Temporality:E13
T15	Eq-Comparison 288 298	at least 1
E15	Eq-Comparison:T15 Operator:T82 Value:T83
T16	Condition 310 316	lesion
E16	Condition:T16 Name:T84 Minimum-Count:E15
T17	Negation 326 329	not
E17	Negation:T17 Negates:E19
T18	Eq-Comparison 335 345	previously
E18	Eq-Comparison:T18 Temporal-Period:T85
T19	Procedure 346 356	irradiated
E19	Procedure:T19 Name:T134 Temporality:E18
T20	Temporal-Connection 363 371	Prior to
E20	Temporal-Connection:T20 Arg:E21 Arg2:E22
A1	Temporal-Connection-Type-Value E20 before
T21	Study 372 382	enrollment
E21	Study:T21 
T22	Observation 394 412	laboratory testing
E22	Observation:T22 Name:T86
T23	Condition 443 448	tumor
E23	Condition:T23 Name:T87 Minimum-Count:E24
T24	Eq-Comparison 453 463	one of two
E24	Eq-Comparison:T24 Value:T88 Value2:T135
T25	Condition 464 485	common EGFR mutations
E25	Condition:T25 Name:T89 Polarity:T90
T26	Procedure 517 533	EGFR-TKI therapy
E26	Procedure:T26 Name:T91
T28	And 547 551	with
E28	And:T28 Arg:E26
T29	Or 552 554	or
E29	Or:T29 Arg:E28 Arg2:E30
T30	Negation 555 558	not
E30	Negation:T30 Negates:E32
T31	Other 576 581	other
E31	Other:T31 Is-Other:E32
T32	Condition 582 595	EGFR mutation
E32	Condition:T32 Name:T92
T33	Exception 606 615	exception
E33	Exception:T33 From:E32 Except:E34
T34	Condition 619 636	exon 20 insertion
E34	Condition:T34 Name:T27
T35	Eq-Comparison 663 682	Previously received
E35	Eq-Comparison:T35 Temporal-Period:T93
T36	Modifier 683 691	systemic
E36	Modifier:T36 Modifies:E37
T37	Procedure 692 701	treatment
E37	Procedure:T37 Temporality:E35
T38	Modifier 706 722	locally advanced
E38	Modifier:T38 Modifies:T94
T39	Or 723 725	or
E39	Or:T39 Arg:E38 Arg2:E40
T40	Modifier 726 746	recurrent metastatic
E40	Modifier:T40 Modifies:T94
T41	Condition 747 753	cancer
E41	Condition:T41 Name:T94
T42	Modifier 760 767	Primary
E42	Modifier:T42 Modifies:T95
T43	Condition 768 782	T790M mutation
E43	Condition:T43 Name:T95 Polarity:T96
T44	Eq-Comparison 806 814	Previous
E44	Eq-Comparison:T44 Temporal-Period:T97
T45	Condition 815 840	interstitial lung disease
E45	Condition:T45 Name:T98 Temporality:E44
T47	Condition 855 880	interstitial lung disease
E47	Condition:T47 Name:T99
T48	Condition 882 901	radiation pneumonia
E48	Condition:T48 Name:T100
T49	Assertion 902 911	requiring
E49	Assertion:T49 Asserted:E50
A2	Assertion-Type-Value E49 hypothetical
T50	Procedure 912 928	hormonal therapy
E50	Procedure:T50 Name:T101
T51	Or 930 932	or
E51	Or:T51 Arg:E50 Arg2:E53
T52	Eq-Comparison 955 961	active
E52	Eq-Comparison:T52 Temporal-Period:T102
T53	Condition 962 987	interstitial lung disease
E53	Condition:T53 Name:T103 Temporality:E52
T54	Eq-Comparison 1000 1006	active
E54	Eq-Comparison:T54 Temporal-Period:T104
T55	Condition 1007 1017	infections
E55	Condition:T55 Name:T105 Temporality:E54
T56	Condition 1026 1037	hepatitis B
E56	Condition:T56 Name:T106
T57	Condition 1039 1050	hepatitis C
E57	Condition:T57 Name:T107
T58	Or 1052 1055	and
E58	Or:T58 Arg:E57 Arg2:E59
T59	Condition 1056 1084	human immunodeficiency virus
E59	Condition:T59 Name:T108
T60	Modifier 1091 1096	Local
E60	Modifier:T60 Modifies:T109
T61	Procedure 1097 1114	radiation therapy
E61	Procedure:T61 Name:T109 Temporality:E62 Temporality2:E63
T62	Eq-Comparison 1118 1129	carried out
E62	Eq-Comparison:T62 Temporal-Period:T137
T63	Eq-Comparison 1130 1143	within 1 week
E63	Eq-Comparison:T63 Operator:T110 Value:T111 Temporal-Unit:T112
T64	Eq-Comparison 1145 1158	more than 30%
E64	Eq-Comparison:T64 Operator:T113 Value:T114 Unit:T115
T65	Procedure 1159 1188	bone marrow radiation therapy
E65	Procedure:T65 Name:T116 Minimum-Count:E64 Temporality:E68
T66	Or 1189 1191	or
E66	Or:T66 Arg:E65 Arg2:E67
T67	Procedure 1202 1219	radiation therapy
E67	Procedure:T67 Name:T118 Severity:T117 Temporality:E68
T68	Eq-Comparison 1233 1247	within 4 weeks
E68	Eq-Comparison:T68 Operator:T119 Value:T120 Temporal-Unit:T121
T69	Eq-Comparison 1254 1263	≤ 4 weeks
E69	Eq-Comparison:T69 Operator:T122 Value:T123 Temporal-Unit:T124
T70	Temporal-Connection 1264 1268	from
E70	Temporal-Connection:T70 Arg:E69 Arg2:E71
A3	Temporal-Connection-Type-Value E70 after
T71	Procedure 1275 1282	surgery
E71	Procedure:T71 Name:T125 Severity:T138
T72	Or 1283 1285	or
E72	Or:T72 Arg:E71 Arg2:E73
T73	Eq-Comparison 1286 1295	≤ 2 weeks
E73	Eq-Comparison:T73 Operator:T126 Value:T127 Temporal-Unit:T128
T74	Temporal-Connection 1296 1300	from
E74	Temporal-Connection:T74 Arg:E73 Arg2:E75
A4	Temporal-Connection-Type-Value E74 after
T75	Procedure 1307 1314	surgery
E75	Procedure:T75 Name:T129 Severity:T139
T76	Procedure-Name 43 56	cytologically
T77	Condition-Name 87 93	cancer
T78	Observation-Name 104 108	ECOG
A5	Observation-Type-Value T78 clinical-score
T79	Eq-Value 140 141	0
T80	Condition-Name 191 196	NSCLC
T81	Eq-Temporal-Period 212 220	received
A6	Eq-Temporal-Period-Value T81 past
T82	Eq-Operator 288 296	at least
A7	Eq-Operator-Value T82 GTEQ
T83	Eq-Value 297 298	1
T84	Condition-Name 310 316	lesion
T85	Eq-Temporal-Period 335 345	previously
A8	Eq-Temporal-Period-Value T85 past
T86	Observation-Name 394 412	laboratory testing
A9	Observation-Type-Value T86 lab
T87	Condition-Name 443 448	tumor
T88	Eq-Value 460 463	two
T89	Condition-Name 464 485	common EGFR mutations
T90	Polarity 486 494	positive
A10	Polarity-Value T90 positive
T91	Procedure-Name 517 533	EGFR-TKI therapy
T92	Condition-Name 582 595	EGFR mutation
T93	Eq-Temporal-Period 663 682	Previously received
A11	Eq-Temporal-Period-Value T93 past
T94	Condition-Name 747 753	cancer
T95	Condition-Name 768 782	T790M mutation
T96	Polarity 783 791	positive
A12	Polarity-Value T96 positive
T97	Eq-Temporal-Period 806 814	Previous
A13	Eq-Temporal-Period-Value T97 past
T98	Condition-Name 815 840	interstitial lung disease
T99	Condition-Name 855 880	interstitial lung disease
T100	Condition-Name 882 901	radiation pneumonia
T101	Procedure-Name 912 928	hormonal therapy
T102	Eq-Temporal-Period 955 961	active
A14	Eq-Temporal-Period-Value T102 present
T103	Condition-Name 962 987	interstitial lung disease
T104	Eq-Temporal-Period 1000 1006	active
A15	Eq-Temporal-Period-Value T104 present
T105	Condition-Name 1007 1017	infections
T106	Condition-Name 1026 1037	hepatitis B
T107	Condition-Name 1039 1050	hepatitis C
T108	Condition-Name 1056 1084	human immunodeficiency virus
T109	Procedure-Name 1097 1114	radiation therapy
T110	Eq-Operator 1130 1136	within
A16	Eq-Operator-Value T110 LTEQ
T111	Eq-Value 1137 1138	1
T112	Eq-Temporal-Unit 1139 1143	week
A17	Eq-Temporal-Unit-Value T112 week
T113	Eq-Operator 1145 1154	more than
A18	Eq-Operator-Value T113 GT
T114	Eq-Value 1155 1157	30
T115	Eq-Unit 1157 1158	%
T116	Procedure-Name 1159 1188	bone marrow radiation therapy
T118	Procedure-Name 1202 1219	radiation therapy
T119	Eq-Operator 1233 1239	within
A20	Eq-Operator-Value T119 LTEQ
T120	Eq-Value 1240 1241	4
T121	Eq-Temporal-Unit 1242 1247	weeks
A21	Eq-Temporal-Unit-Value T121 week
T122	Eq-Operator 1254 1255	≤
A22	Eq-Operator-Value T122 LTEQ
T123	Eq-Value 1256 1257	4
T124	Eq-Temporal-Unit 1258 1263	weeks
A23	Eq-Temporal-Unit-Value T124 week
T125	Procedure-Name 1275 1282	surgery
T126	Eq-Operator 1286 1287	≤
A24	Eq-Operator-Value T126 LTEQ
T127	Eq-Value 1288 1289	2
T128	Eq-Temporal-Unit 1290 1295	weeks
A25	Eq-Temporal-Unit-Value T128 week
T129	Procedure-Name 1307 1314	surgery
T130	Procedure-Name 25 39	Histologically
R1	Found-By Arg1:E6 Arg2:E1	
R2	Found-By Arg1:E6 Arg2:E3	
T131	Eq-Value 142 143	1
T132	Eq-Operator 141 142	-
A26	Eq-Operator-Value T132 BETWEEN
R3	Treatment-For Arg1:E14 Arg2:E12	
T133	Negation 206 211	never
E76	Negation:T133 Negates:E14
T134	Procedure-Name 346 356	irradiated
R4	Treatment-For Arg1:E19 Arg2:E16	
R5	Found-By Arg1:E23 Arg2:E22	
T135	Eq-Value 453 456	one
R6	Caused-By Arg1:E25 Arg2:E23	
R7	Treatment-For Arg1:E26 Arg2:E25	
T136	Assertion 504 516	sensitive to
E77	Assertion:T136 Asserted:E26
A27	Assertion-Type-Value E77 hypothetical
T27	Condition-Name 619 636	exon 20 insertion
R8	Treatment-For Arg1:E37 Arg2:E41	
T46	Drug 842 846	drug
E27	Drug:T46 
R9	Caused-By Arg1:E47 Arg2:E27	
R10	Treatment-For Arg1:E50 Arg2:E48	
R11	Example-Of Arg1:E56 Arg2:E55	
R12	Example-Of Arg1:E57 Arg2:E55	
R13	Example-Of Arg1:E59 Arg2:E55	
T137	Eq-Temporal-Period 1118 1129	carried out
A28	Eq-Temporal-Period-Value T137 past
T117	Severity 1192 1201	extensive
A19	Severity-Value T117 severe
T138	Severity 1269 1274	major
A29	Severity-Value T138 severe
T139	Severity 1301 1306	minor
A30	Severity-Value T139 mild
